Do you still think Cardinal Health, Inc (NYSE:CAH) is worth a look?

Stocks of Cardinal Health, Inc (NYSE:CAH) traded higher last session on Wall Street, up 0.39% to $128.26.

CAH stock price is now 5.25% away from the 50-day moving average and 17.31% away from the 200-day moving average. The market capitalization of the company currently stands at $31.04B.

With the price target enhanced from $130 to $144, TD Cowen Upgraded its rating from Hold to Buy for Cardinal Health, Inc (NYSE: CAH). On January 07, 2025, Evercore ISI Upgraded its previous ‘In-line’ rating to ‘Outperform’ on the stock keeping its target price maintained at $140, while ‘BofA Securities’ rates the stock as ‘Buy’

In other news, Scherer Mary C., Chief Accounting Officer sold 3,504 shares of the company’s stock on Nov 14 ’24. The stock was sold for $432,919 at an average price of $123.55. Upon completion of the transaction, the Chief Accounting Officer now directly owns 8,752 shares in the company, valued at $1.12 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 21 ’24, Chief Legal/Compliance Officer Mayer Jessica L sold 16,573 shares of the business’s stock. A total of $1,812,920 was realized by selling the stock at an average price of $109.39. This leaves the insider owning 75,971 shares of the company worth $9.74 million. A total of 0.28% of the company’s stock is owned by insiders.

During the past 12 months, Cardinal Health, Inc has had a low of $93.17 and a high of $131.29. According to the stock market information, the enterprise value for the company is $33217261568, which is based on a 23.92 price-to-earnings ratio, a 2.63 price-to-earnings-growth ratio, and a beta of 0.65. The fifty day moving average price for CAH is $121.7244 and a two-hundred day moving average price translates $109.21475 for the stock.

The latest earnings results from Cardinal Health, Inc (NYSE: CAH) was released for 2024-09-30. The company reported revenue of $52.28 billion for the quarter, compared to $54.65 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -4.34 percent.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.